Pacific Biosciences
PACB
$11.33
Share price
-2.16%
Change (1 day)
2.91%
Change (1 year)
Revenue for Pacific Biosciences (PACB)
Revenue in 2022 (TTM): $0.13 B
According to Pacific Biosciences 's latest financial reports the company's current revenue (TTM) is $0.13 B. In 2021 the company made a revenue of $0.13 B an increase over the years 2020 revenue that were of $78.89 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Pacific Biosciences from 2010 to 2022
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2022 (TTM) | $0.13 B | 4.95% |
| 2021 | $0.13 B | 65.43% |
| 2020 | $78.89 M | -13.2% |
| 2019 | $90.89 M | 15.6% |
| 2018 | $78.62 M | -15.88% |
| 2017 | $93.46 M | 3.04% |
| 2016 | $90.71 M | -2.23% |
| 2015 | $92.78 M | 53.12% |
| 2014 | $60.59 M | 115.02% |
| 2013 | $28.18 M | 8.46% |
| 2012 | $25.98 M | -23.27% |
| 2011 | $33.86 M | 1922.88% |
| 2010 | $1.67 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $44.16 B | 32,145.75% | 🇺🇸 USA |
 General Electric GE | $76.55 B | 55,791.07% | 🇺🇸 USA |
 Illumina ILMN | $4.69 B | 3,330.68% | 🇺🇸 USA |
 PerkinElmer
PKI | $4.56 B | 3,232.95% | 🇺🇸 USA |
 Luminex LMNX | N/A | N/A | 🇺🇸 USA |
 NanoString Technologies NSTG | $0.13 B | -1.22% | 🇺🇸 USA |